Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Acute Myocardial Infarction: Curations of Cardiovascular Original Research A Bibliography

Curators: Aviva Lev-Ari, PhD, RN and Larry H Bernstein, MD, FCAP

This article covers CURATIONS on one topic in Cardiology: Acute Myocardial Infarction. It represents a Bibliography on the subject matter using the Methodology of Curation.

The e-Reader is advised to read the article that describes what is this methodology and what makes it particularly appropriate for analysis, synthesis, interpretation and exposition of Medical Research Findings.

conceived: NEW Definition for Co-Curation in Medical Research

http://pharmaceuticalintelligence.com/2014/01/04/conceived-new-definition-for-co-curation-in-medical-research/

The e-Reader is advised to review the Curation methodology applied to case studies on Cardiovascular Diseases in the following volume:

Cardiovascular Original Research:

Cases in Methodology Design for Content Co-Curation

The Art of Scientific & Medical Curation

by

Justin D Pearlman, MD, PhD, FACC

Larry H Bernstein, MD, FCAP 

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/biomed-e-books/series-a-e-books-on-cardiovascular-diseases/volume-two-cardiovascular-original-research-cases-in-methodology-design-for-content-co-curation/

Acute Myocardial Infarction: Curations of Cardiovascular Original Research A Bibliography from the Open Access Online Scientific Journal

http://pharmaceuticalintelligence.com

• A Software Agent for Diagnosis of ACUTE MYOCARDIAL INFARCTION

Isaac E. Mayzlin, Ph.D, David Mayzlin, Larry H. Bernstein, M.D

http://pharmaceuticalintelligence.com/2012/08/12/1815/

• Response to Rosuvastatin in Patients With Acute Myocardial Infarction: Hepatic Metabolism and Transporter Gene Variants Effect

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2014/01/02/response-to-rosuvastatin-in-patients-with-acute-myocardial-infarction-hepatic-metabolism-and-transporter-gene-variants-effect/

• MicroRNA in Serum as Bimarker for Cardiovascular Pathologies: acute myocardial infarction, viral myocarditis,  diastolic dysfunction, and acute heart failure

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/12/12/microrna-in-serum-as-bimarker-for-cardiovascular-pathologies-acute-myocardial-infarction-viral-myocarditis-diastolic-dysfunction-and-acute-heart-failure/

• Acute and Chronic Myocardial Infarction: Quantification of Myocardial Perfusion Viability – FDG-PET/MRI vs. MRI or PET alone

Justin Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/05/22/acute-and-chronic-myocardial-infarction-quantification-of-myocardial-viability-fdg-petmri-vs-mri-or-pet-alone/

• Atherosclerosis Independence: Genetic Polymorphisms of Ion Channels Role in the Pathogenesis of Coronary Microvascular Dysfunction and Myocardial Ischemia (Coronary Artery Disease (CAD))

Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/12/21/genetic-polymorphisms-of-ion-channels-have-a-role-in-the-pathogenesis-of-coronary-microvascular-dysfunction-and-ischemic-heart-disease/

• Myocardial Damage in Cardiovascular Disease: Circulating MicroRNA-208b and MicroRNA-499

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/12/12/myocardial-damage-in-cardiovascular-disease-circulating-microrna-208b-and-microrna-499/

• Intracoronary Transplantation of Progenitor Cells after Acute MI

Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/11/02/progenitor-cells-coronary-graft-after-ami/

• Myocardial Infarction: The New Definition After Revascularization

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/10/15/myocardial-infarction-the-new-definition-after-revascularization/

• Coronary Circulation Combined Assessment: Optical Coherence Tomography (OCT),Near-Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) – Detection of Lipid-Rich Plaque and Prevention of Acute Coronary Syndrome (ACS)

Justin Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/08/25/coronary-circulation-combined-assessment-optical-coherence-tomography-oct-near-infrared-spectroscopy-nirs-and-intravascular-ultrasound-ivus-detection-of-lipid-rich-plaque-and-prevention-of-a/

• Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/06/30/troponin-i-in-acute-decompensated-heart-failure/

• Microchemistry Implant Device for Early Detection of Acute Coronary Syndrome

Larry H Bernstein, MD, FACP

http://pharmaceuticalintelligence.com/2013/03/26/microchemistry-implant-device/

• Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study

Larry H Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/06/30/troponin-i-in-acute-decompensated-heart-failure/

• Acute Chest Pain/ER Admission: Three Emerging Alternatives to Angiography and PCI – Corus CAD, hs cTn, CCTA

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2013/03/10/acute-chest-painer-admission-three-emerging-alternatives-to-angiography-and-pci/

• Clinical Trials Results for Endothelin System: Pathophysiological role in Chronic Heart Failure, Acute Coronary Syndromes and MI – Marker of Disease Severity or Genetic Determination?

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2012/10/19/clinical-trials-results-for-endothelin-system-pathophysiological-role-in-chronic-heart-failure-acute-coronary-syndromes-and-mi-marker-of-disease-severity-or-genetic-determination/

• Amplifying Information Using S-Clustering and Relationship to Kullback-Liebler Distance: An Application to Myocardial Infarction

Reporter and curator: Larry H Bernstein, MD, FCAP

http://pharmaceuticalintelligence.com/2012/09/22/amplifying-information-using-s-clustering/

• Human embryonic pluripotent stem cells and healing post-myocardial infarction

Larry H. Bernstein, MD, FCAP

http://pharmaceuticalintelligence.com/2012/08/07/human-embryonic-pluripotent-stem-cells-and-healing-post-myocardial-infarction/

• Diagnostic Value of Cardiac Biomarkers

Larry H Bernstein, MD, FCAP

http://pharmaceuticalintelligence.com/2014/01/04/diagnostic-value-of-cardiac-biomarkers/

• On-Hours vs Off-Hours: Presentation to ER with Acute Myocardial Infarction – Lower Survival Rate if Off-Hours

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2014/01/22/on-hours-vs-off-hours-presentation-to-er-with-acute-myocardial-infarction-lower-survival-rate-if-off-hours/